Literature DB >> 15326489

Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching.

Debora Degl'Innocenti1, Elena Arighi, Anna Popsueva, Romina Sangregorio, Luisella Alberti, Maria Grazia Rizzetti, Cristina Ferrario, Hannu Sariola, Marco A Pierotti, Maria Grazia Borrello.   

Abstract

The receptor tyrosine kinase RET is alternatively spliced to yield two main isoforms, RET9 and RET51, which differ in their carboxyl terminal. Activated RET induces different biological responses such as morphological transformation, neurite outgrowth, proliferation, cell migration and branching. The two isoforms have been suggested to have separate intracellular signaling pathways and different roles in mouse development. Here we show that both isoforms are able to induce cell scattering of SK-N-MC neuroepithelioma cell line and branching tubule formation in MDCK cell line. However, the Y1062F mutation, which abrogates the transforming activity of both activated RET isoforms in NIH3T3 cells, does not abolish scattering and branching morphogenesis of RET51, whereas impairs these biological effects of RET9. The GDNF-induced biological effects of RET51 are inhibited by the simultaneous abrogation of both Tyr1062 and Tyr1096 docking sites. Thus, Tyr1096 may substitute the functions of Tyr1062. GRB2 is the only known adaptor protein binding to Tyr1096. Dominant-negative GRB2 expressed in MDCK cells together with RET9 or RET51 significantly reduces branching. Therefore, GRB2 is necessary for RET-mediated branching of MDCK cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326489     DOI: 10.1038/sj.onc.1207862

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Anti-tumor activity of motesanib in a medullary thyroid cancer model.

Authors:  A Coxon; J Bready; S Kaufman; J Estrada; T Osgood; J Canon; L Wang; R Radinsky; R Kendall; P Hughes; A Polverino
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

2.  Critical and distinct roles for key RET tyrosine docking sites in renal development.

Authors:  Sanjay Jain; Mario Encinas; Eugene M Johnson; Jeffrey Milbrandt
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

3.  RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Authors:  Giuliana Cassinelli; Enrica Favini; Debora Degl'Innocenti; Alessandro Salvi; Giuseppina De Petro; Marco A Pierotti; Franco Zunino; Maria Grazia Borrello; Cinzia Lanzi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

4.  Cellular localization of GDNF and its GFRalpha1/RET receptor complex in the developing pancreas of cat.

Authors:  C Lucini; L Maruccio; B Facello; N Cocchia; G Tortora; L Castaldo
Journal:  J Anat       Date:  2008-11       Impact factor: 2.610

5.  PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney.

Authors:  Doyeob Kim; Gregory R Dressler
Journal:  Dev Biol       Date:  2007-05-08       Impact factor: 3.582

6.  Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice.

Authors:  Sanjay Jain; Amanda Knoten; Masato Hoshi; Hongtao Wang; Bhupinder Vohra; Robert O Heuckeroth; Jeffrey Milbrandt
Journal:  J Clin Invest       Date:  2010-02-15       Impact factor: 14.808

7.  Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform.

Authors:  Adrianne Wong; Silvia Bogni; Pille Kotka; Esther de Graaff; Vivette D'Agati; Frank Costantini; Vassilis Pachnis
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.